Movement Disorders Program
The Movement Disorders Program evaluates, diagnoses, and treats all movement disorders including:- Tremors
- Parkinson’s disease
- Dystonia
- Restless leg syndrome
- Huntington’s disease or chorea
Dr. Way is the principal investigator of the PROSEEK study at Renown. PROSEEK is a drug trial that is studying a c-Abl inhibitor developed by SUN pharmaceuticals that has shown promise in slowing the progression of Parkinson’s disease. To be a candidate for the study, one must fulfill at least the following criteria:
- Age > 50 years
- Diagnosed with Parkinson’s disease within the last 3 years
- Not on medication for treatment of Parkinson’s disease aside from monoamine oxidase B (MAOB) inhibitors.
The PROSEEK Study is a clinical research study evaluating a once-daily, oral
investigational drug for people with early-stage Parkinson’s disease (PD). The
investigational drug is designed to block a specific enzyme called “Abl.” Research
has shown that overactivation of Abl may play a role in PD progression. Therefore, by
limiting or blocking Abl, it may be possible to help to slow PD progression.
Programs & Services
- Acute Rehabilitation
- Acute Care Therapy
- Epilepsy Program
- Headache Program
- Interventional Neuroradiology
- Memory Disorders Program
- Movement Disorders Program
- Multiple Sclerosis Program
- Neurodiagnostics
- Outpatient Therapy
- Neuro ICU
- Neurology
- Neurosciences
- Neurosciences Clinical Trials
- Neurosurgery
- Neurotrauma
- Neurovascular & Stroke Program
- Physiatry
- Spine, Sports & Pain Management
Related Providers
Christopher Way, DO
Neurology
Related Articles
When it comes to your neurological health, seeking the expertise of a specialist is crucial. The Renown Institute for Neurosciences provides comprehensive care for complex diseases affecting brain, spinal cord and peripheral nerves. Let us...
It’s true that a road trip can change your life, and it did for Sergeant Brandon Ott, just not in the way he was expecting. For nine years, Brandon worked alongside his friend, Denton Tipler, at the police department in Florence, Oregon....
There are nearly 1 million adults living with MS in the United States alone. For comparison, that is roughly the entire population of the Reno/Sparks and Las Vegas areas combined. MS is a neurological autoimmune condition which means that...